Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
Lambert
P D
PD
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Gross
R
R
Nemeroff
C B
CB
Kilts
C D
CD
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001921:Brain / Q000502:physiology*; D003024:Clozapine / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D006220:Haloperidol / Q000494:pharmacology; D009496:Neurotensin / Q000502:physiology*; D011720:Pyrazoles / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000502:physiology*; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors / Q000502:physiology*; D012559:Schizophrenia / Q000503:physiopathology; D015398:Signal Transduction
D014150:Antipsychotic Agents; D011720:Pyrazoles; D011804:Quinolines; D011954:Receptors, Dopamine; D018028:Receptors, Neurotensin; C079087:SR 48692; D009496:Neurotensin; D000242:Cyclic AMP; D003024:Clozapine; D006220:Haloperidol; D004298:Dopamine